Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RPGLIFE | NSE
-74.65
-3.25%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
17/09/2024
2,225.30
2,300.00
2,311.45
2,193.25
RPG Life Sciences Limited an integrated pharmaceutical company develops manufactures and markets branded formulations generic and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories including immunosuppressants anti-psychotic anti-anginal anthelmentics anti-convulsant anti-spasmodic etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies such as nephrology rheumatology oncology gastroenterology cardiovascular diabetology orthopedics neuropsychiatry respiratory nutritional general urology anti-diabetic anti-dengue vitamins and minerals gynecology and pediatrics etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
View LessLow Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
46.8%1 month
35.8%3 months
50.4%6 months
40.8%43.29
-
10.05
-
-
26.90
6.31
-
1.33B
37.14B
443.57M
0.70
20.42
21.10
11.90
25.69
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
365.70
Range1M
365.70
Range3M
907.00
Rel. volume
0.56
Price X volume
45.26M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 401 | 40.21B | -0.67% | 46.93 | 62.51% |
Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 146.34 | 37.58B | -0.22% | 14.02 | 0.42% |
Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 375.1 | 34.70B | 2.08% | 46.10 | 60.54% |
Suven Life Sciences Limited | SUVEN | Drug Manufacturers-Specialty & Generic | 157.11 | 34.26B | -4.59% | n/a | 0.26% |
SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 742.95 | 32.02B | -2.19% | n/a | 107.90% |
IOL Chemicals and Pharmaceuticals Limited | IOLCP | Drug Manufacturers-Specialty & Generic | 492.25 | 28.90B | -3.50% | 25.17 | 2.03% |
Themis Medicare Limited | THEMISMED | Drug Manufacturers-Specialty & Generic | 275.25 | 25.38B | -1.56% | 49.52 | 25.36% |
Syncom Formulations (India) Limited | SYNCOMF | Drug Manufacturers-Specialty & Generic | 23.86 | 22.81B | -4.22% | 83.97 | 25.16% |
Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 779.25 | 22.51B | -0.87% | 53.49 | 0.60% |
Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 2453.25 | 20.90B | 0.82% | 104.10 | 83.75% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
V2 Retail Limited | V2RETAIL | Apparel Retail | 1147.65 | 39.70B | 1.48% | 133.29 | 191.28% |
Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 33.05 | 28.31B | -2.91% | 82.05 | 10.74% |
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 185.77 | 27.39B | 0.19% | 29.68 | 43.67% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 227.83 | 23.44B | -0.81% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 109.13 | 3.49B | 4.60% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 169.14 | 1.88B | 5.00% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 98.53 | 1.41B | -0.47% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 37.62 | 1.05B | -0.11% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.04 | 481.85M | -0.85% | 88.75 | 43.14% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 15.73 | 355.84M | -5.58% | n/a | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 26.90 | - | Par |
Ent. to Revenue | 6.31 | - | Cheaper |
PE Ratio | 43.29 | 47.84 | Par |
Price to Book | 10.05 | 6.55 | Expensive |
Dividend Yield | 0.70 | - | Par |
Std. Deviation (3M) | 50.37 | - | Riskier |
Debt to Equity | - | 0.34 | - |
Debt to Assets | - | 0.17 | - |
Market Cap | 37.14B | - | Emerging |